Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
| ▸ | KCNQ3 | O43525 | 4/20 | 0.35 |
| ▸ | KCNQ2 | O43526 | 4/20 | 0.35 |
| ▸ | KCNQ5 | Q9NR82 | 2/20 | 0.35 |
| ▸ | CHUK | O15111 | 1/20 | 0.35 |
| ▸ | RAPGEF3 | O95398 | 1/20 | 0.34 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | KCNE1 | P15382 | 2/20 | 0.34 |
| ▸ | KCNQ1 | P51787 | 2/20 | 0.34 |
| ▸ | GRM4 | Q14833 | 2/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | HTR5A | P47898 | 3/20 | 0.33 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.32 |
| ▸ | RAF1 | P04049 | 1/20 | 0.32 |
| ▸ | CES2 | O00748 | 1/20 | 0.32 |
| ▸ | CES1 | P23141 | 1/20 | 0.32 |
| ▸ | SLC10A1 | Q14973 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18159987 | 0.90 | CYP2D6 (0.50) | CYP2D6CHUKMEN1KMT2AGRM4 | |
| SCHEMBL16797226 | 0.89 | CYP2D6 (0.42) | CYP2D6KCNQ3KCNQ2KCNQ5CHUK | |
| SCHEMBL16797227 | 0.89 | CYP2D6 (0.42) | CYP2D6KCNQ3KCNQ2KCNQ5CHUK | |
| SCHEMBL9920888 | 0.85 | NPC1 (0.43) | CYP2D6KCNQ3KCNQ2KCNQ5RAPGEF3 | |
| SCHEMBL19592072 | 0.81 | CYP2D6 (0.42) | CYP2D6KCNQ3KCNQ2KCNQ5RAPGEF3 | |
| SCHEMBL18162883 | 0.79 | CYP2D6 (0.53) | CYP2D6CHUKRAPGEF3RAPGEF4MEN1 | |
| SCHEMBL18557848 | 0.79 | RAB9A (0.42) | CYP2D6KCNQ3KCNQ2KCNQ5MEN1 | |
| SCHEMBL18557714 | 0.79 | CYP2D6 (0.39) | CYP2D6KCNQ3KCNQ2KCNQ5MEN1 | |
| SCHEMBL19041677 | 0.78 | CYP2D6 (0.39) | CYP2D6KCNQ3KCNQ2KCNQ5RAPGEF3 | |
| SCHEMBL18162905 | 0.78 | CYP2D6 (0.52) | CYP2D6KCNQ3KCNQ2KCNQ5RAPGEF3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9815791-B2 | Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | LYCERA CORPORATION (US) | 2017-11-14 | — | — | US | disclosed |
| US-9815791-B2 | Alkylpyrazolyl guanidine F1F0-ATPase inhibitors and therapeutic uses thereof | LYCERA CORPORATION (US) | 2017-11-14 | — | — | US | disclosed |
| US-20160304465-A1 | ALKYLPYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF | WILMINGTON TRUST, NATIONAL ASSOCIATION | 2016-10-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160304465-A1 | ALKYLPYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF | ATP5F1A, ATP5F1D, ATP5ME | CYP2D6 1739/4885KCNQ3 1665/4885KCNQ2 1352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.